Nanobac Pharmaceuticals, Incorporated
NNBP · OTC
12/31/2007 | 12/31/2006 | 12/31/2005 | 12/31/2004 | |
|---|---|---|---|---|
| Market Cap | $11,879 | $23,931 | $6,988 | $22,171 |
| - Cash | $4 | $40 | $9 | $18 |
| + Debt | $4,122 | $5,367 | $2,486 | $256 |
| Enterprise Value | $15,997 | $29,259 | $9,464 | $22,409 |
| Revenue | $18 | $225 | $657 | $358 |
| % Growth | -92.2% | -65.7% | 83.3% | – |
| Gross Profit | $3 | $145 | $427 | $258 |
| % Margin | 17.6% | 64.5% | 65.1% | 72% |
| EBITDA | -$5,929 | -$4,233 | -$2,857 | -$6,883 |
| % Margin | -33,646.8% | -1,880.6% | -434.9% | -1,920.8% |
| Net Income | -$6,576 | -$4,973 | -$3,687 | -$7,875 |
| % Margin | -37,319.7% | -2,209.5% | -561.4% | -2,197.4% |
| EPS Diluted | 0 | -0.025 | -0.02 | -0.052 |
| % Growth | 100% | -27.7% | 62.1% | – |
| Operating Cash Flow | -$911 | -$2,585 | -$2,365 | -$3,396 |
| Capital Expenditures | -$2 | -$13 | -$41 | -$37 |
| Free Cash Flow | -$912 | -$2,598 | -$2,406 | -$3,433 |